HDAC6-IN-31
HDAC6-IN-31 (compound 8m) is a selective HDAC6 inhibitor, with the IC50 value of 0.026 μM, that significantly inhibits the production and release of pro-inflammatory cytokines. While HDAC6 is critically involved in the activation of inflammasomes, HDAC6-IN-31 has the potential to inhibit NLRP3 inflammasome-driven inflammatory diseases. HDAC6-IN-31 also inhibits glioblastoma cell migration[1].
Product Specifications
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hdac6-in-31.html
Solubility
10 mM in DMSO
Smiles
FC1=C(NC2=C(C)N=C3N2C=CC=C3)C=CC(C(NO)=O)=C1
Molecular Formula
C15H13FN4O2
Molecular Weight
300.29
References & Citations
[1]Kraft FB, et al. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties. Bioorg Chem. 2024 Feb;143:107072.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC683393-500 1x 500 µL
Drebrin 1 (DBN1) (DBN1/3393), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 